[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies].

By E. von Elm, Douglas G. Altman, Matthias Egger, Stuart J. Pocock, P. Gøtzsche, Jan P. Vandenbroucke. Revista Española de Salud Pública, 2008

2,135 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/aaec2a0232189c61a08692c0ffa1b1f68e8d62b3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus (2008, unknown): “Lin et al,35 2007 (Taiwan) C Lymphoma (nonHodgkin) 20002004 30 y, AIDS, DM diagnosed 1 y prior to cancer diagnosis, prior malignancy 26/242 (11) Median, 59 142 (59) NA Nonec”
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. (2007, methodology): “This paper is linked to the shorter STROBE paper that introduced the items of the checklist in several journals [6], and forms an integral part of the STROBE Statement.”
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. (2011, methodology): “In the data extraction stage we obtained information about study design and participants as recommended by the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines [17,18], parallel to the CONSORT guidelines for reporting of randomized trials [19].”
On the Plurality of (Methodological) Worlds: Estimating the Analytic Flexibility of fMRI Experiments (2012, unknown): “…been widely adopted by academic journals that publish studies of randomized controlled trials (Moher et al., 2001), diagnostic accuracy (Bossuyt et al., 2003), and observational epidemiology (von Elm et al., 2007), can significantly improve the quality of methods reporting (Plint et al., 2006).”
The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) Study: Comparative Effectiveness of a Time-varying Treatment with Competing Risks (2013, unknown): “At admission Age, y 38 (24-54) 1244 37 (24-53) 904 Male, No.”
Inflammation and sarcopenia: A systematic review and meta-analysis. (2017, unknown): “4 Assessment of study quality Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) criteria [13] were used for the quality assessment of included studies.”